GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tissue Regenix Group PLC (LSE:TRX) » Definitions » PB Ratio

Tissue Regenix Group (LSE:TRX) PB Ratio : 1.83 (As of May. 22, 2024)


View and export this data going back to 2006. Start your Free Trial

What is Tissue Regenix Group PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-22), Tissue Regenix Group's share price is £0.62. Tissue Regenix Group's Book Value per Share for the quarter that ended in Dec. 2023 was £0.34. Hence, Tissue Regenix Group's PB Ratio of today is 1.83.

The historical rank and industry rank for Tissue Regenix Group's PB Ratio or its related term are showing as below:

LSE:TRX' s PB Ratio Range Over the Past 10 Years
Min: 0.14   Med: 2.34   Max: 11.79
Current: 1.83

During the past 13 years, Tissue Regenix Group's highest PB Ratio was 11.79. The lowest was 0.14. And the median was 2.34.

LSE:TRX's PB Ratio is ranked better than
63.79% of 1323 companies
in the Biotechnology industry
Industry Median: 2.53 vs LSE:TRX: 1.83

During the past 12 months, Tissue Regenix Group's average Book Value Per Share Growth Rate was -7.40% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -6.50% per year. During the past 5 years, the average Book Value Per Share Growth Rate was -36.80% per year. During the past 10 years, the average Book Value Per Share Growth Rate was -23.40% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Tissue Regenix Group was 29.80% per year. The lowest was -50.70% per year. And the median was -8.10% per year.

Back to Basics: PB Ratio


Tissue Regenix Group PB Ratio Historical Data

The historical data trend for Tissue Regenix Group's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tissue Regenix Group PB Ratio Chart

Tissue Regenix Group Annual Data
Trend Jan14 Jan15 Jan16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 1.31 1.46 1.55 1.54

Tissue Regenix Group Semi-Annual Data
Jan14 Jul14 Jan15 Jul15 Jan16 Jul16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.46 1.22 1.55 1.48 1.54

Competitive Comparison of Tissue Regenix Group's PB Ratio

For the Biotechnology subindustry, Tissue Regenix Group's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tissue Regenix Group's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tissue Regenix Group's PB Ratio distribution charts can be found below:

* The bar in red indicates where Tissue Regenix Group's PB Ratio falls into.



Tissue Regenix Group PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Tissue Regenix Group's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=0.62/0.338
=1.83

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Tissue Regenix Group  (LSE:TRX) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Tissue Regenix Group PB Ratio Related Terms

Thank you for viewing the detailed overview of Tissue Regenix Group's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Tissue Regenix Group (LSE:TRX) Business Description

Traded in Other Exchanges
Address
Lotherton Way, Unit 3, Phoenix Court, Garforth, GBR, LS25 2GY
Tissue Regenix Group PLC is a pioneering medical technology company engaged in the development of regenerative products. The company incorporates dCELL and BioRinse technology, which helps to address complex and varying clinical needs. Its product portfolio includes Biosurgery, Orthopaedics, and Dental. The company has operations around the world, with special emphasis in the United States.

Tissue Regenix Group (LSE:TRX) Headlines

From GuruFocus

Tanzanian Gold Reports Annual Meeting Voting Results

By GlobeNewswire GlobeNewswire 02-28-2020

Tanzanian Gold Clarifies Disclosure

By GlobeNewswire GlobeNewswire 02-21-2020

TanGold Announces Board and Management Change

By GlobeNewswire GlobeNewswire 01-21-2021